Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...
Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...
Europe's health regulator has recommended the approval of GSK's cancer treatment Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy, the ...
An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...
The elite athlete was competing in powerlifting events when she was shocked to be diagnosed with breast cancer. She found a ...
We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores. These don’t tend to cause us much worry because they’re usually symptoms of benign issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback